UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors: New among Antidiabetic Drugs

Cardiovascular drugs and therapy, 2014-08, Vol.28 (4), p.331-334

Opie, L. H.

2014

Volltextzugriff (PDF)

A role for the RISK pathway and KATP channels in pre‐ and post‐conditioning induced by levosimendan in the isolated guinea pig heart

British journal of pharmacology, 2008-05, Vol.154 (1), p.41-50

2008

Volltextzugriff (PDF)

Aspirin in the prevention of cancer

The Lancet (British edition), 2011-05, Vol.377 (9778), p.1651-1651

Opie, LH

2011

Volltextzugriff (PDF)

Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias

The Lancet, 1994-01, Vol.343 (8890), p.155-158

1994

Volltextzugriff (PDF)

Reperfusion injury and its pharmacologic modification

Circulation (New York, N.Y.), 1989-10, Vol.80 (4), p.1049-1062

Opie, L H

1989

Volltextzugriff (PDF)

Beta-blockers for hypertension

Cochrane database of systematic reviews, 2007-01 (1), p.CD002003

2007

Volltextzugriff (PDF)

South African hypertension guideline 2006

South African medical journal, 2006-04, Vol.96 (4), p.337-362

2006

Volltextzugriff (PDF)

Renoprotection by angiotensin-receptor blockers and ACE inhibitors in hypertension

The Lancet (British edition), 2001-12, Vol.358 (9296), p.1829-1831

Opie, LH

2001

Volltextzugriff (PDF)

Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning

Cardiovascular research, 2008-07, Vol.79 (1), p.127-133

2008

Volltextzugriff (PDF)

Hypertension, Platelets, and Inflammatory Responses

Cardiovascular drugs and therapy, 2014-06, Vol.28 (3), p.291-292

Opie, L. H.

2014

Volltextzugriff (PDF)

A role for the RISK pathway and K ATP channels in pre‐ and post‐conditioning induced by levosimendan in the isolated guinea pig heart

British journal of pharmacology, 2009-01, Vol.154 (1), p.41-50

2009

Volltextzugriff (PDF)

The effect of left ventricular remodelling on soluble ST2 in a cohort of hypertensive subjects

Journal of human hypertension, 2014-07, Vol.28 (7), p.432-437

2014

Volltextzugriff (PDF)

Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart

The Journal of pharmacology and experimental therapeutics, 1999-08, Vol.290 (2), p.505

1999

Volltextzugriff (PDF)

Digitalis reappraised: Still here today, but gone tomorrow?

SAMJ: South African Medical Journal, 2015-02, Vol.105 (2), p.88-89

Opie, Lionel H

2015

Volltextzugriff (PDF)

Nifedipine and mortality. Grave defects in the dossier

Circulation (New York, N.Y.), 1995-09, Vol.92 (5), p.1068-1073

1995

Volltextzugriff (PDF)

Enhanced Angiotensin II Activity in Heart Failure: Reevaluation of the Counterregulatory Hypothesis of Receptor Subtypes

Circulation research, 2001-04, Vol.88 (7), p.654-658

2001

Volltextzugriff (PDF)

Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle

Journal of the American College of Cardiology, 2000-12, Vol.36 (7), p.2296-2302

2000

Volltextzugriff (PDF)

Protons in ischemia: Where do they come from; Where do they go to?

Journal of molecular and cellular cardiology, 1991-09, Vol.23 (9), p.1077-1086

1991

Volltextzugriff (PDF)

Is a High Glycogen Content Beneficial or Detrimental to the Ischemic Rat Heart?: A Controversy Resolved

Circulation research, 1996-03, Vol.78 (3), p.482-491

1996

Volltextzugriff (PDF)

Modulation of Severity of Reperfusion Stunning in the Isolated Rat Heart by Agents Altering Calcium Flux at Onset of Reperfusion

Circulation research, 1992-05, Vol.70 (5), p.960-967

1992

Volltextzugriff (PDF)

Cardiovascular prevention: lifestyle and statins--competitors or companions?

SAMJ: South African Medical Journal, 2014-03, Vol.104 (3), p.168-173

2014

Volltextzugriff (PDF)

Reduction of Ischemic K+ Loss and Arrhythmias in Rat Hearts: Effect of Glibenclamide, a Sulfonylurea

Circulation research, 1990-02, Vol.66 (2), p.478-485

1990

Volltextzugriff (PDF)

Glucose and glycogen utilisation in myocardial ischemia--changes in metabolism and consequences for the myocyte

Molecular and cellular biochemistry, 1998-03, Vol.180 (1-2), p.3-26

1998

Volltextzugriff (PDF)

Pharmacological differences between calcium antagonists

European heart journal, 1997-01, Vol.18 (suppl-A), p.71-79

Opie, L H

1997

Volltextzugriff (PDF)

Proof that glucose-insulin-potassium provides metabolic protection of ischaemic myocardium?

The Lancet (British edition), 1999-03, Vol.353 (9155), p.768-769

Opie, LH

1999

Volltextzugriff (PDF)

1 – 25 von 781

Menü

Weitere Dienste

Einstellungen

Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors: New among Antidiabetic Drugs

A role for the RISK pathway and KATP channels in pre‐ and post‐conditioning induced by levosimendan in the isolated guinea pig heart

Aspirin in the prevention of cancer

Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias

Reperfusion injury and its pharmacologic modification

Beta-blockers for hypertension

South African hypertension guideline 2006

Renoprotection by angiotensin-receptor blockers and ACE inhibitors in hypertension

Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning

Hypertension, Platelets, and Inflammatory Responses

A role for the RISK pathway and K ATP channels in pre‐ and post‐conditioning induced by levosimendan in the isolated guinea pig heart

The effect of left ventricular remodelling on soluble ST2 in a cohort of hypertensive subjects

Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart

Digitalis reappraised: Still here today, but gone tomorrow?

Nifedipine and mortality. Grave defects in the dossier

Enhanced Angiotensin II Activity in Heart Failure: Reevaluation of the Counterregulatory Hypothesis of Receptor Subtypes

Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle

Protons in ischemia: Where do they come from; Where do they go to?

Is a High Glycogen Content Beneficial or Detrimental to the Ischemic Rat Heart?: A Controversy Resolved

Modulation of Severity of Reperfusion Stunning in the Isolated Rat Heart by Agents Altering Calcium Flux at Onset of Reperfusion

Cardiovascular prevention: lifestyle and statins--competitors or companions?

Reduction of Ischemic K+ Loss and Arrhythmias in Rat Hearts: Effect of Glibenclamide, a Sulfonylurea

Glucose and glycogen utilisation in myocardial ischemia--changes in metabolism and consequences for the myocyte

Pharmacological differences between calcium antagonists

Proof that glucose-insulin-potassium provides metabolic protection of ischaemic myocardium?

Suchergebnisse filtern